Heart Failure (HF) and Atrial Fibrillation (AF) are two of the most common cardiovascular diseases worldwide, both entailing an increased morbidity and mortality [1,2] Sharing common risk factors and a robust pathophysiological relationship, these two conditions commonly occur together [3], imposing a significant challenge to treating physicians, particularly in the management of antithrombotic treatment and rhythm and rate control strategy [4].
